Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Maes

Showing results (131-140 of 323) with videos related to

Pageof 33
Sort By:
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1984
Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levelsA P van der Vet, R H Drost, J Kreukniet, et al.
Journal of Chromatography|April 8, 1983
Simultaneous determination of amiodarone and its major metabolite desethylamiodarone in plasma, urine and tissues by high-performance liquid chromatographyT A Plomp, M Engels, E O Robles de Medina, et al.
Clinical Nuclear Medicine|June 21, 2001
Ga-67-positive and F-18 FDG-negative imaging in well-differentiated hepatocellular carcinomaF J Braga, P Flamen, L Mortelmans, et al.
Acta Neurologica Belgica|February 20, 2002
Guidelines for brain radionuclide imaging. Perfusion single photon computed tomography (SPECT) using Tc-99m radiopharmaceuticals and brain metabolism positron emission tomography (PET) using F-18 fluorodeoxyglucose. The Belgian Society for Nuclear MedicineT Vander Borght, P Laloux, A Maes, et al.
The New England Journal of Medicine|June 12, 1980
Delta-9-tetrahydrocannabinol (THC) as an antiemeticJ C Kluin-Nelemans, O J Meuwissen, F A Nelemans, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1985
Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (Theograd, 350 mg Theolair Retard, and 300 mg Theolin Retard) in steady state in six normals and six patients with chronic asthmatic bronchitis--Part II: Lung functionA P van der Vet, J Kreukniet, R H Drost, et al.
The British Journal of Ophthalmology|October 1, 1990
Scleral melting in a patient with conjunctival rhinosporidiosisR M De Doncker, R J de Keizer, J A Oosterhuis, et al.
European Journal of Pharmacology|January 16, 1995
The corticosterone-enhancing effects of the 5-HT1A receptor antagonist, (S)-UH301, are not mediated by the 5-HT1A receptorL Groenink, J Van der Gugten, J Mos, et al.
Nuclear Medicine Communications|March 22, 2001
The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapyF van Acker, P Flamen, P Lambin, et al.
Journal of Evaluation in Clinical Practice|September 30, 2017
Documentation of pharmaceutical care: Validation of an intervention oriented classification systemKaren A Maes, Helene Studer, Jérôme Berger, et al.
Pageof 33

Showing results (131-140 of 323) with videos related to

Sort By:
Pageof 33
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1984
Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levelsA P van der Vet, R H Drost, J Kreukniet, et al.
Journal of Chromatography|April 8, 1983
Simultaneous determination of amiodarone and its major metabolite desethylamiodarone in plasma, urine and tissues by high-performance liquid chromatographyT A Plomp, M Engels, E O Robles de Medina, et al.
Clinical Nuclear Medicine|June 21, 2001
Ga-67-positive and F-18 FDG-negative imaging in well-differentiated hepatocellular carcinomaF J Braga, P Flamen, L Mortelmans, et al.
Acta Neurologica Belgica|February 20, 2002
Guidelines for brain radionuclide imaging. Perfusion single photon computed tomography (SPECT) using Tc-99m radiopharmaceuticals and brain metabolism positron emission tomography (PET) using F-18 fluorodeoxyglucose. The Belgian Society for Nuclear MedicineT Vander Borght, P Laloux, A Maes, et al.
The New England Journal of Medicine|June 12, 1980
Delta-9-tetrahydrocannabinol (THC) as an antiemeticJ C Kluin-Nelemans, O J Meuwissen, F A Nelemans, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1985
Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (Theograd, 350 mg Theolair Retard, and 300 mg Theolin Retard) in steady state in six normals and six patients with chronic asthmatic bronchitis--Part II: Lung functionA P van der Vet, J Kreukniet, R H Drost, et al.
The British Journal of Ophthalmology|October 1, 1990
Scleral melting in a patient with conjunctival rhinosporidiosisR M De Doncker, R J de Keizer, J A Oosterhuis, et al.
European Journal of Pharmacology|January 16, 1995
The corticosterone-enhancing effects of the 5-HT1A receptor antagonist, (S)-UH301, are not mediated by the 5-HT1A receptorL Groenink, J Van der Gugten, J Mos, et al.
Nuclear Medicine Communications|March 22, 2001
The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapyF van Acker, P Flamen, P Lambin, et al.
Journal of Evaluation in Clinical Practice|September 30, 2017
Documentation of pharmaceutical care: Validation of an intervention oriented classification systemKaren A Maes, Helene Studer, Jérôme Berger, et al.
Pageof 33